US regulators have finalized a new set of recommendations intended to make infusion pumps safer and more reliable. In the US, medical devices can come to market in a variety of different ways. Some ...
Hospira ($HSP) now faces a Class I recall--the FDA's most serious--because of malfunctioning problems with the company's Symbiq infusion pump system. The designation ...
The U.S. Food and Drug Administration (FDA) issued a warning letter to Hospira, Inc., about problems with alarm systems in its infusion pumps, according to a Reuters report. Hospira said the letter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results